From: Efficacy of 104-week Telbivudine-based optimization strategy in patients with HBeAg-negative chronic hepatitis B virus infections
CK
Baseline
Week 12
Week 24
Week 36
Week 52
Week 72
Week 104
Grade 1, n
14
22
26
29
38
31
42
Grade 2, n
0
3
19
13
16
Grade 3, n
1
2
6
Grade 4, n
Total, n
25
44
60
50
58